• 1. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 2. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267
• 3. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 4. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

Methyl 2,4-difluoro-6-nitrobenzoate (CAS No. 1807183-16-9): A Comprehensive Overview

Methyl 2,4-difluoro-6-nitrobenzoate (CAS No. 1807183-16-9) is a fluorinated nitrobenzoate derivative that has garnered significant attention in the field of medicinal chemistry and materials science due to its unique structural and functional properties. This compound, characterized by its 2,4-difluoro and 6-nitro substituents, exhibits a range of applications that span from pharmaceutical intermediates to advanced material synthesis.

The chemical structure of Methyl 2,4-difluoro-6-nitrobenzoate consists of a benzoic acid backbone esterified with a methyl group at the carboxyl position, while the aromatic ring is functionalized with two fluorine atoms at the 2 and 4 positions and a nitro group at the 6 position. This specific arrangement imparts distinct electronic and steric properties to the molecule, making it a valuable candidate for various synthetic and analytical applications.

In recent years, the study of fluorinated aromatic compounds has seen remarkable advancements, particularly in their role as key intermediates in drug development. The presence of fluorine atoms in Methyl 2,4-difluoro-6-nitrobenzoate enhances its metabolic stability and lipophilicity, which are crucial factors in pharmaceutical design. Furthermore, the nitro group contributes to its reactivity, allowing for further functionalization through reduction or nucleophilic substitution reactions.

One of the most compelling aspects of Methyl 2,4-difluoro-6-nitrobenzoate is its potential application in the synthesis of bioactive molecules. Researchers have leveraged its structural features to develop novel compounds with therapeutic potential. For instance, derivatives of this compound have been explored as inhibitors of various enzymes and receptors involved in metabolic disorders and inflammatory diseases. The fluorine atoms play a pivotal role in modulating the binding affinity and selectivity of these derivatives, thereby enhancing their efficacy.

The role of Methyl 2,4-difluoro-6-nitrobenzoate in materials science is equally noteworthy. Its unique electronic properties make it suitable for use in organic electronics, including light-emitting diodes (LEDs) and organic photovoltaics (OPVs). The presence of both fluorine and nitro groups allows for fine-tuning of the molecule's energy levels, which is essential for optimizing device performance. Recent studies have demonstrated its utility in creating high-efficiency electron-transport materials that contribute to improved charge separation and transport in optoelectronic devices.

The synthesis of Methyl 2,4-difluoro-6-nitrobenzoate involves a multi-step process that typically begins with the nitration of fluorene or a related precursor to introduce the nitro group at the desired position. Subsequent halogenation followed by esterification yields the final product. The use of advanced synthetic techniques such as palladium-catalyzed cross-coupling reactions has further refined the production process, enabling higher yields and purities.

In terms of analytical methods, Methyl 2,4-difluoro-6-nitrobenzoate can be characterized using various spectroscopic techniques such as nuclear magnetic resonance (NMR) spectroscopy, infrared (IR) spectroscopy, and mass spectrometry (MS). These methods provide detailed information about its molecular structure and purity. High-performance liquid chromatography (HPLC) is commonly employed for quantitative analysis due to its high resolution and sensitivity.

The safety profile of Methyl 2,4-difluoro-6-nitrobenzoate is another critical consideration. While it is not classified as a hazardous substance under standard regulatory guidelines, proper handling procedures should be followed to minimize exposure. Personal protective equipment (PPE), such as gloves and safety goggles, is recommended during handling to prevent skin and eye contact. Additionally, adequate ventilation should be ensured to avoid inhalation of any dust or vapors.

The future prospects for Methyl 2,4-difluoro-6-nitrobenzoate are promising, with ongoing research focusing on expanding its applications in drug discovery and materials science. The development of new synthetic methodologies will continue to enhance its accessibility and versatility. Furthermore, computational studies using density functional theory (DFT) are being employed to predict the reactivity and properties of this compound more accurately.

In conclusion, Methyl 2,4-difluoro-6-nitrobenzoate (CAS No. 1807183-16-9) is a multifaceted compound with significant potential across multiple scientific disciplines. Its unique structural features make it an invaluable tool for researchers working on pharmaceuticals and advanced materials. As our understanding of its properties continues to grow, so too will its applications in addressing some of the most pressing challenges in modern science.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)